ArticleACS pharmacology & translational science2025

Screening for Antileukemia Agents in FMS-like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia Cells.

Livia Bassani Lins de Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.